To (1) identify unique features of patients who underwent middle ear/mastoid obliteration with blind-sac closure of the external auditory canal for spontaneous cerebrospinal fluid (CSF) otorrhea and (2) explore outcomes.
Study Design
Case series with chart review.
Setting
Tertiary care center.
Subjects and Methods
Adults treated for spontaneous cerebrospinal fluid otorrhea from 2007 through 2015 were reviewed and stratified into 2 groups based on the surgery performed: (1) 11 patients underwent middle ear/mastoid obliteration with blind-sac closure of the external auditory canal and (2) 26 patients underwent other procedures. Demographics, body mass index, revised cardiac risk index, Duke Activity Status Index scores, and anticoagulation use were documented. Audiologic data were gathered from pre- and postoperative visits. The primary outcome measure was leak recurrence. Complications were tabulated.
Results
Poor preoperative hearing was a relative indication for obliteration. Obliteration patients had higher body mass index (43.2 vs 34.9 kg/m2; P < .05), incidence of super-morbid obesity (45% vs 7.6%; P = .015), anticoagulation usage (36% vs 0%; P = .004), cardiac risk scores (1.2 vs 0.1 dB; P < .0004), and Duke Activity Status Index scores. There was 1 leak recurrence (9%). Major and minor complication rates were 9% and 36%, respectively. Mean follow-up was 30.8 ± 8.6 months.
Conclusion
Middle ear and mastoid obliteration with blind-sac closure of the external auditory canal is effective for treating spontaneous CSF otorrhea. The small cohort reviewed did not experience any major perioperative morbidity. The technique may be best suited for patients with poor hearing, the infirm, and those in whom craniotomy is contraindicated.
NelsonRFGantzBJHansenMR.The rising incidence of spontaneous cerebrospinal fluid leaks in the United States and the association with obesity and obstructive sleep apnea. Otol Neurotol. 2015;36:476-480.
3.
SugermanHJFeltonWLIIISalvantJBJr. Effects of surgically induced weight loss on idiopathic intracranial hypertension in morbid obesity. Neurology. 1995;45:1655-1659.
4.
SugermanHJDeMariaEJFeltonWLIII. Increased intra-abdominal pressure and cardiac filling pressures in obesity-associated pseudotumor cerebri. Neurology. 1997;49:507-511.
5.
StevensSMLambertPRRizkH. Novel radiographic measurement algorithm demonstrating a link between obesity and lateral skull base attenuation. Otolaryngol Head Neck Surg. 2015;152:172-179.
6.
O’ConnellBPStevensSMXiaoCCMeyerTASchlosserRJ.Lateral skull base attenuation in patients with anterior cranial fossa spontaneous cerebrospinal fluid leaks. Otolaryngol Head Neck Surg. 2016;154:1138-1144.
7.
RizkHGHatchJLStevensSMLambertPRMeyerTA.Lateral skull base attenuation in superior semicircular canal dehiscence and spontaneous cerebrospinal fluid otorrhea. Otolaryngol Head Neck Surg. 2016;155:641-648.
8.
NelsonRFHansenKRGantzBJHansenMR.Calvarium thinning in patients with spontaneous cerebrospinal fluid leak. Otol Neurotol. 2015;36:481-485.
9.
PsaltisAJOvertonLJThomasWWIIIFoxNFBanksCASchlosserRJ.Differences in skull base thickness in patients with spontaneous cerebrospinal fluid leaks. Am J Rhinol Allergy. 2014;28:e73-e79.
10.
KimLWiselyCEDodsonEE.Transmastoid approach to spontaneous temporal bone cerebrospinal fluid leaks: hearing improvement and success of repair. Otolaryngol Head Neck Surg. 2014;150:472-478.
11.
CarlsonMLCopelandWRIIIDriscollCL. Temporal bone encephalocele and cerebrospinal fluid fistula repair utilizing the middle cranial fossa or combined mastoid-middle cranial fossa approach. J Neurosurg. 2013;119:1314-1322.
12.
SannaMFoisPRussoAFalcioniM.Management of meningoencephalic herniation of the temporal bone: personal experience and literature review. Laryngoscope. 2009;119:1579-1585.
13.
SouliereCRJrLangmanAW.Combined mastoid/middle cranial fossa repair of temporal bone encephalocele. Skull Base Surg. 1998;8:185-189.
14.
JacksonCGPappasDGJrManolidisS. Brain herniation into the middle ear and mastoid: concepts in diagnosis and surgical management. Am J Otol. 1997;18:198-206.
15.
MosnierIFikyLEShahidiASterkersO.Brain herniation and chronic otitis media: diagnosis and surgical management. Clin Otolaryngol Allied Sci. 2000;25:385-391.
16.
NahasZTatlipinarALimbCJFrancisHW.Spontaneous meningoencephalocele of the temporal bone: clinical spectrum and presentation. Arch Otolaryngol Head Neck Surg. 2008;134:509-518.
17.
ScurryWCJrOrtSAPetersonWMSheehanJMIsaacsonJE.Idiopathic temporal bone encephaloceles in the obese patient. Otolaryngol Head Neck Surg. 2007;136:961-965.
18.
LundyLBGrahamMDKartushJMLaRouereMJ.Temporal bone encephalocele and cerebrospinal fluid leaks. Am J Otol. 1996;17:461-469.
19.
GubbelsSPSeldenNRDelashawJBJrMcMenomeySO.Spontaneous middle fossa encephalocele and cerebrospinal fluid leakage: diagnosis and management. Otol Neurotol. 2007;28:1131-1139.
20.
SdanoMTPensakML.Temporal bone encephaloceles. Curr Opin Otolaryngol Head Neck Surg. 2005;13:287-289.
21.
KuczkowskiJNiemczykKStankiewiczCPilarskaESzurowskaEPlichtaL.Lateral petrosectomy with obliteration cavity for spontaneous cerebrospinal otorrhea in children. Am J Otolaryngol. 2014;35:651-654.
22.
LeonettiJPMarzoSAndersonDOrigitanoTVukasDD.Spontaneous transtemporal CSF leakage: a study of 51 cases. Ear Nose Throat J. 2005;84:700-704, 706.
23.
RamalingamKKRamalingamRSreenivasaMurthyTMChandrakalaGR.Management of temporal bone meningo-encephalocoele. J Laryngol Otol. 2008;122:1168-1174.
24.
HlatkyMABoineauREHigginbothamMB. A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am J Cardiol. 1989;64:651-654.
25.
FleisherLABeckmanJABrownKA. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. J Am Coll Cardiol. 2007;50:1707-1732.
26.
GoldmanLCalderaDLNussbaumSR. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med. 1977;297:845-850.
27.
LeeTHMarcantonioERMangioneCM. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999;100:1043-1049.
28.
BernardeschiDNguyenYSmailM. Middle ear and mastoid obliteration for cochlear implant in adults: indications and anatomical results. Otol Neurotol. 2015;36:604-609.
29.
LeungRBriggsRJ.Indications for and outcomes of mastoid obliteration in cochlear implantation. Otol Neurotol. 2007;28:330-334.
30.
IssingPRSchonermarkMPWinkelmannSKempfHGErnstA.Cochlear implantation in patients with chronic otitis: indications for subtotal petrosectomy and obliteration of the middle ear. Skull Base Surg. 1998;8:127-131.
31.
BendetECerenkoDLinderTEFischU.Cochlear implantation after subtotal petrosectomies. Eur Arch Otorhinolaryngol. 1998;255:169-174.
32.
GrayRFRayJMcFerranDJ.Further experience with fat graft obliteration of mastoid cavities for cochlear implants. J Laryngol Otol. 1999;113:881-884.
33.
PasanisiEVincentiVBacciuA. Multichannel cochlear implantation in radical mastoidectomy cavities. Otolaryngol Head Neck Surg. 2002;127:432-436.
34.
FreeRHFalcioniMDi TrapaniGGiannuzziALRussoASannaM.The role of subtotal petrosectomy in cochlear implant surgery—a report of 32 cases and review on indications. Otol Neurotol. 2013;34:1033-1040.
35.
VincentiVPasanisiEBacciuABacciuS.Long-term results of external auditory canal closure and mastoid obliteration in cochlear implantation after radical mastoidectomy: a clinical and radiological study. Eur Arch Otorhinolaryngol. 2014;271:2127-2130.
36.
WongMCShippDBNedzelskiJMChenJMLinVY.Cochlear implantation in patients with chronic suppurative otitis media. Otol Neurotol. 2014;35:810-814.
37.
SannaMDispenzaFFlanaganSDe StefanoAFalcioniM.Management of chronic otitis by middle ear obliteration with blind sac closure of the external auditory canal. Otol Neurotol. 2008;29:19-22.
38.
KetelslagersKSomersTDe FoerBZarowskiAOffeciersE.Results, hearing rehabilitation, and follow-up with magnetic resonance imaging after tympanomastoid exenteration, obliteration, and external canal overclosure for severe chronic otitis media. Ann Otol Rhinol Laryngol. 2007;116:705-711.
39.
McMurphyABOghalaiJS.Repair of iatrogenic temporal lobe encephalocele after canal wall down mastoidectomy in the presence of active cholesteatoma. Otol Neurotol. 2005;26:587-594.
40.
WoottenCTKaylieDMWarrenFMJacksonCG.Management of brain herniation and cerebrospinal fluid leak in revision chronic ear surgery. Laryngoscope. 2005;115:1256-1261.
41.
GacekRR.Mastoid and middle ear cavity obliteration for control of otitis media. Ann Otol Rhinol Laryngol. 1976;85:305-309.
42.
BlackB.Mastoidectomy elimination: obliterate, reconstruct, or ablate?Am J Otol. 1998;19:551-557.
43.
FantuzziG.Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol. 2005;115:911-920.
44.
Sanchez-MargaletVMartin-RomeroCSantos-AlvarezJGobernaRNajibSGonzalez-YanesC.Role of leptin as an immunomodulator of blood mononuclear cells: mechanisms of action. Clin Exp Immunol. 2003;133:11-19.
45.
La CavaAAlviggiCMatareseG. Unraveling the multiple roles of leptin in inflammation and autoimmunity. J Mol Med (Berl). 2004;82:4-11.
